Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115960652 | 11596065 | 2 | F | 2010 | 20160912 | 20151006 | 20160919 | EXP | US-ABBVIE-15K-163-1471922-00 | ABBVIE | 65.64 | YR | F | Y | 72.64000 | KG | 20160919 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115960652 | 11596065 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | U | 1041343 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | |||||
| 115960652 | 11596065 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | U | 1041343 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | |||||
| 115960652 | 11596065 | 3 | C | CEPHALEXIN. | CEPHALEXIN | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 4 | C | NIFEDIPINE. | NIFEDIPINE | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 5 | C | NIFEDIPINE. | NIFEDIPINE | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 7 | C | POTASSIUM | POTASSIUM | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 8 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 9 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 10 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 11 | C | VITAMIN B3 | NIACIN | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 12 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 13 | C | LUMIGAN | BIMATOPROST | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 14 | C | COMBIGAN | BRIMONIDINE TARTRATETIMOLOL MALEATE | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 15 | C | ALLEGRA-D | FEXOFENADINEPSEUDOEPHEDRINE | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 16 | C | CHLORZOXAZONE. | CHLORZOXAZONE | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 17 | C | XANAX | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 115960652 | 11596065 | 18 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 115960652 | 11596065 | 1 | Rheumatoid arthritis |
| 115960652 | 11596065 | 3 | Infection prophylaxis |
| 115960652 | 11596065 | 4 | Hypertension |
| 115960652 | 11596065 | 5 | Raynaud's phenomenon |
| 115960652 | 11596065 | 6 | Fluid retention |
| 115960652 | 11596065 | 7 | Mineral supplementation |
| 115960652 | 11596065 | 8 | Neuralgia |
| 115960652 | 11596065 | 9 | Rheumatoid arthritis |
| 115960652 | 11596065 | 10 | Depression |
| 115960652 | 11596065 | 11 | Vitamin supplementation |
| 115960652 | 11596065 | 12 | Blood cholesterol increased |
| 115960652 | 11596065 | 13 | Glaucoma |
| 115960652 | 11596065 | 14 | Glaucoma |
| 115960652 | 11596065 | 15 | Hypersensitivity |
| 115960652 | 11596065 | 16 | Pain |
| 115960652 | 11596065 | 17 | Anxiety |
| 115960652 | 11596065 | 18 | Arthralgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 115960652 | 11596065 | HO |
| 115960652 | 11596065 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 115960652 | 11596065 | Arthralgia | |
| 115960652 | 11596065 | Arthritis | |
| 115960652 | 11596065 | Attention deficit/hyperactivity disorder | |
| 115960652 | 11596065 | Cellulitis | |
| 115960652 | 11596065 | Chills | |
| 115960652 | 11596065 | Erythema | |
| 115960652 | 11596065 | Exostosis | |
| 115960652 | 11596065 | Fatigue | |
| 115960652 | 11596065 | Feeling hot | |
| 115960652 | 11596065 | Ingrowing nail | |
| 115960652 | 11596065 | Intervertebral disc protrusion | |
| 115960652 | 11596065 | Pain in extremity | |
| 115960652 | 11596065 | Peripheral swelling | |
| 115960652 | 11596065 | Respiratory tract infection | |
| 115960652 | 11596065 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 115960652 | 11596065 | 1 | 2010 | 20150823 | 0 | |
| 115960652 | 11596065 | 2 | 201509 | 0 |